A new Japanese medical firm, Cyfuse Biomedical (Tokyo, Japan), is embarking on a most unique application of 3D printing. The goal of their research effort is to create new blood vessels. Koji Kuchiishi is the CEO of the firm; his previous endeavors include mobile phone design (at Panasonic), a patent associate, and a stint as a McKinsey consultant. His firm has significant venture backing (JAFCO, the largest Japanese Venture Capital firm and the University of Tokyo Edge Capital Fund, among others). Cyfuse’s developments are “protected” by patents in the US, China, Singapore, and Japan.
Continue reading Blood Vessels for Dialysis
Share this:
